At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BIAF bioAffinity Technologies, Inc.
Market Closed 10-30 16:00:00 EDT
2.91
-0.12
-3.96%
盘后2.90
-0.01-0.34%
19:57 EDT
High3.04Low2.86Vol47.27K
Open3.04D1 Closing3.03Amplitude5.90%
Mkt Cap3.73MTradable Cap3.71MTotal Shares1.28M
T/O139.49KT/O Rate3.71%Tradable Shares1.28M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

bioAffinity Technologies Attends Battle of the Blues Lung Cancer Event
Reuters  ·  10-29 20:04
bioAffinity Technologies Attends Battle of the Blues Lung Cancer Event
BioAffinity to present new perspectives on CyPath Lung at CHEST 2026
TIPRANKS  ·  10-15
BioAffinity to present new perspectives on CyPath Lung at CHEST 2026
bioAffinity Technologies Hosts CHEST Presentation on CyPath Lung Cancer Risk Assessment
Reuters  ·  10-15
bioAffinity Technologies Hosts CHEST Presentation on CyPath Lung Cancer Risk Assessment
bioAffinity Technologies to Present Data on Sputum-Based Asthma, COPD Inflammation Test at CHEST 2026
Reuters  ·  10-13
bioAffinity Technologies to Present Data on Sputum-Based Asthma, COPD Inflammation Test at CHEST 2026
Wallachbeth Capital Announces Closing of bioAffinity Technologies $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-the-Market Under NASDAQ Rules
THOMSON REUTERS  ·  10-10
Wallachbeth Capital Announces Closing of bioAffinity Technologies $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-the-Market Under NASDAQ Rules
BioAffinity Technologies Prices $4 Million Registered Direct Offering
MT Newswires Live  ·  10-09
BioAffinity Technologies Prices $4 Million Registered Direct Offering
bioAffinity Technologies Inc trading halted, volatility trading pause
TIPRANKS  ·  10-09
bioAffinity Technologies Inc trading halted, volatility trading pause
BioAffinity Technologies announces $4M registered direct offering
TIPRANKS  ·  10-09
BioAffinity Technologies announces $4M registered direct offering
bioAffinity Sells Warrants in Private Placement for up to 980,072 Shares
Reuters  ·  10-09
bioAffinity Sells Warrants in Private Placement for up to 980,072 Shares
NASDAQ Trade Halt Volatility Trading Pause at 12:07 Pm
Reuters  ·  10-09
NASDAQ Trade Halt Volatility Trading Pause at 12:07 Pm
bioAffinity Technologies, Inc. Announces Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-the-Market Under NASDAQ Rules
THOMSON REUTERS  ·  10-09
bioAffinity Technologies, Inc. Announces Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-the-Market Under NASDAQ Rules
bioAffinity Technologies Wins Japan Patent Allowance for CyPath Lung AI Algorithm
Reuters  ·  10-08
bioAffinity Technologies Wins Japan Patent Allowance for CyPath Lung AI Algorithm
BioAffinity reports over 100% growth in CyPath Lung sales through Q3
TIPRANKS  ·  10-06
BioAffinity reports over 100% growth in CyPath Lung sales through Q3
bioAffinity Says CyPath Lung Test Sales More than Double Through Q3 2026
Reuters  ·  10-06
bioAffinity Says CyPath Lung Test Sales More than Double Through Q3 2026
bioAffinity Technologies Partners with AvMEDICAL to Distribute CyPath Lung Test Across Federal Healthcare Market
Reuters  ·  09-30
bioAffinity Technologies Partners with AvMEDICAL to Distribute CyPath Lung Test Across Federal Healthcare Market
BioAffinity to present clinical, veteran-focused data on CyPath Lung
TIPRANKS  ·  09-22
BioAffinity to present clinical, veteran-focused data on CyPath Lung
bioAffinity Launches 2,000-Patient FlowPath Lung Study Testing CyPath Lung in Veteran, Military Populations
Reuters  ·  09-22
bioAffinity Launches 2,000-Patient FlowPath Lung Study Testing CyPath Lung in Veteran, Military Populations
Top Midday Gainers
MT Newswires Live  ·  09-18
Top Midday Gainers
bioAffinity Technologies Inc trading halted, volatility trading pause
TIPRANKS  ·  09-18
bioAffinity Technologies Inc trading halted, volatility trading pause
BioAffinity Technologies announces grant of Hong Kong patent for CyPath Lung
TIPRANKS  ·  09-17
BioAffinity Technologies announces grant of Hong Kong patent for CyPath Lung

Introduction

Company Name.
bioAffinity Technologies, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.
Issue price:
--